Willow Biosciences Inc. (TSX:WLLW)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
May 1, 2025, 10:34 AM EDT
Willow Biosciences Company Description
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.
The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients.
Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc.
| Country | Canada |
| Founded | 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Chris Savile |
Contact Details
Address: 202, 1201-5th Street SW Calgary, Alberta T2R 0Y6 Canada | |
| Phone | 403-910-5140 |
| Website | willowbio.com |
Stock Details
| Ticker Symbol | WLLW |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA97111B4047 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Chris Savile | President, Director and Chief Executive Officer |
| Travis Doupe | Chief Financial Officer |
| Dr. Trish Choudhary | Senior Vice President of Research and Development |
| Sanjib Singh Gill L.L.B. | Corporate Secretary |